Peter has served as our Chief Financial Officer since September 2020. Mr. Slover previously served as the Chief Financial Officer for Sophiris Bio, Inc., or Sophiris, from January 2013 to May 2020 and as the Head of Finance and Principal Accounting Officer of Sophiris from April 2012 to January 2013. From April 2004 to April 2012, Mr. Slover held a variety of significant management positions at Anadys Pharmaceuticals, including Vice President, Finance and Operations, a position that he held from July 2009 to April 2012, Senior Director, Finance and Corporate Controller, Senior Manager, Financial Reporting and Internal Controls, and Manager of Financial Reporting. Prior to joining Anadys, Mr. Slover was an auditor at KPMG LLP, where he spent seven years in public accounting.
Peter is a Certified Public Accountant in the State of California (inactive). He received a B.S. in Business Administration from Shippensburg University in 1997.